$BIAF 3 SEC Filings

Filed On	Filing
25 Sep 2025	Form 3: Rios Roberto, Director Holds 833 shares of Common Stock
25 Sep 2025	Form 3: Oppenheimer John J., Director No securities owned
20 Sep 2024	Form 3: Edwards James Michael, Interim CFO Holds 13,956 shares of Common Stock, par value $0.007
08 Dec 2023	Form 3: Platt Jamie, Director No securities owned
26 Sep 2023	Form 3: Joyce Roby, Director Holds 583,130 shares of Common Stock
25 Sep 2023	Form 3: Reveles Xavier Trinidad, Chief Operating Officer Holds 3,619 shares of Common Stock
11 May 2023	Form 3: Dougherty Michael Philip, Chief Financial Officer No securities owned
07 Mar 2023	Form 3: Perlmutter Nathan M, 10% owner Holds 166,089 shares of Common Stock, par value $0.007
07 Mar 2023	Form 3: Meghji Mohsin Y, Director Holds 28,571 shares of Common Stock, par value $0.007
05 Dec 2022	Form 3: Zannes Timothy P, Secretary, EVP, Gen. Counsel
05 Dec 2022	Form 3: Knight Peter S, Director Holds 14,285 shares of Common Stock, par value $0.007
02 Dec 2022	Form 3: Anderson Robert A., Director
02 Dec 2022	Form 3: Diamond Stuart, Director
29 Nov 2022	Form 3: Edwards James Michael, Chief Financial Officer Holds 27,875 shares of Common Stock, par value $0.007
22 Nov 2022	Form 3: Rebel Vivienne I, EVP, Chief Sci. & Med. Officer Holds 7,142 shares of Common Stock, par value $0.007
22 Nov 2022	Form 3: Zannes Maria, Director Holds 3,571 shares of Common Stock, par value $0.007
08 Nov 2022	Form 3: Girgenti Steven, Director Holds 249,278 shares of Common Stock, par value $0.007
21 Oct 2022	Form 3: Rubin Gary D, Director and 1 other Holds 35,714 shares of Common Stock, par value $0.007

Comments